Orphenadrine Citrate
- Product NDC
- 69784-905
- 11-digit product format
- 697840905
- Labeler code
- 69784
- Product ID
- 69784-905_60b2e28d-8356-60dd-e053-2a91aa0a3c5a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Orphenadrine Citrate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Woodward Pharma Services LLC
- Application
- ANDA040249
- Marketing category
- ANDA
- Marketing start
- 2017-05-26
- Marketing end
- 0000-00-00
- Substance
- ORPHENADRINE CITRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69784-905 | ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [WOODWARD PHARMA SERVICES LLC] | 3 | Legacy NDC | 20171219_5b317bfd-633d-0ce1-e053-2991aa0aa4c3.zip |